- Expertise and services
- Science and research
- Education and publications
- About us
SEOTP is a Phase IV clinical trial to improve and innovate existing treatment approaches for psychosis based on genotype and endophenotype, including pharmacokinetic analysis, to minimise the adverse effects of olanzapine treatment and to provide further information on the efficacy of this treatment.
The clinical trial is conducted by Masaryk University. The patients participating in the trial are under the care of the principal investigators, Prof. Libor Ustohal, M.D., Ph.D., from the Psychiatric Clinic of the University Hospital Brno, and Petr Šilhán, M.D., Ph.D., from the Psychiatric Department of the University Hospital Ostrava, and their colleagues.
Clinical trials have been initiated in all participating centres but have not yet started. Of the total number of patients planned to be enrolled (200), 0 patients are currently enrolled.
SEOTP National Coordinator
Assoc. PharmDr. Jan Juřica, Ph.D.
Ing Karolína Grodová | firstname.lastname@example.org
RECRUITMENT OF PATIENTS